Agency / Source: Argutus Medical Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Argutus Medical Receives ISO 13485 Quality Management System Certification - Argutus Medical Ltd, an EKF Diagnostics Company announces that its Quality Management System has received ISO 13485:2003 certification. The assessment was carried out by the notified body BSI (British Standards Institute) - ArgutusMed.com
Argutus Medical Receives ISO 13485 Quality Management System Certification

 

PRZOOM - /newswire/ - Dublin, Ireland, 2012/09/04 - Argutus Medical Ltd, an EKF Diagnostics Company announces that its Quality Management System has received ISO 13485:2003 certification. The assessment was carried out by the notified body BSI (British Standards Institute) - ArgutusMed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Argutus Medical Ltd, an EKF Diagnostics Company (AIM: EKF), is pleased to announce that it’s Quality Management System has been certified as fulfilling the requirements of ISO 13485:2003. The scope of this certification covers the Design, Development, manufacture and distribution of in-vitro diagnostic biomarkers to assess organ damage.

The assessment of Argutus Medical’s Quality Management System was performed by British Standards Institute (BSI), a world leader among notified bodies.

Joe Keenan, General Manager at Argutus Medical welcomed this significant landmark and said that the completion of the audits is evidence of the company’s persistence in maintaining only the highest quality products. "At Argutus, we are constantly striving to uphold the highest quality standards for our company and our products," he said. "Earning these certifications shows that our pursuit of quality is paying off and it will benefit our customers greatly."

As a globally recognised quality management system certification for medical devices and related services, receipt of ISO 13485 certification confirms Argutus Medical’s ongoing commitment to meet the requirements of its customers and regulatory bodies.

About Argutus Medical Ltd, an EKF Diagnostics Company

Argutus Medical Ltd (argutusmed.com) is a world leader in the development, manufacture and supply of a variety of test kits for the early detection of injury to organs such as the kidney and liver. Argutus Medical is based in Dublin, Ireland and since 2010 has been part of EKF Diagnostics Holdings plc (AIM:EKF) a publicly listed Healthcare company that is headquartered in Cardiff, Wales, UK.

EKF Diagnostics Holdings plc specialises in the development, manufacture and distribution of point of care analysers for hemoglobin, HbA1c, glucose, lactate as well as a range of clinical chemistry products and biomarker-based ELISA & rapid tests. EKF Diagnostics has nine sites in six countries and employs 295 people as of 31 December 2011.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Argutus Medical Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Argutus Medical Receives ISO 13485 Quality Management System Certification

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Joe Keenan - ArgutusMed.com 
+353 1 670 8576 info[.]argutusmed.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Argutus Medical Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Argutus Medical Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen to Present 12 Abstracts At the 11th World Congress for Neurorehabilitation (WCNR) Virtual Congress
Imec Announces elPrep5 - the Newest Version of its Software Platform for DNA Analysis
Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress
Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced
Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting
DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market
DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Garrison Minerals, LLC

Visit  Limelon Advertising, Co.

Visit  JobsWare.com







 
  ©2020 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today